SightfileU.S. market data from official filings
Companies › SNY
SANOFI SA (SNY)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001121404 · EDGAR filings · Updated 2026-07-28
SANOFI SA (SNY) has reported institutional ownership of 17.2%, with 735 institutional managers holding positions valued at $10.1B per the latest 13F reporting period.
Institutional ownership
17.2%
Institutional managers
735
Reported 13F value
$10.1B
Filings this week (3)
- 2026-07-28 — Institutional holdings report (13F) filed
- 2026-07-27 — Foreign issuer report (6-K) filed
- 2026-07-22 — SCHEDULE 13G/A filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-17 — Foreign issuer report (6-K) filed
- 2026-07-07 — Foreign issuer report (6-K) filed
- 2026-06-30 — 11-K filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, SANOFI SA has 735 institutional holders and institutional ownership of 17.2%.
Related companies
BIOMARIN PHARMACEUTICAL INC (BMRN) · BEONE MEDICINES LTD (ONC) · REVVITY INC (RVTY) · CYTOKINETICS INC (CYTK) · DAVITA INC (DVA) · MASIMO CORP (MASI)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.